Biological
Allogeneic Tumor Cell Vaccine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
National Cancer Institute (NCI) (1) · Mayo Clinic (1) · Hadassah Medical Organization (1)
Often tested with
Tested in the same studies.
Celecoxib (1) · Cyclophosphamide (1) · Therapeutic Autologous Dendritic Cells (1)
Studies
Open first, then newest update. How each study uses Allogeneic Tumor Cell Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 3
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedPhase 1National Cancer Institute (NCI)NCT01143545Written as Allogeneic Tumor Cell Vaccine (K562)
- Vaccine Therapy in Treating Patients With Non-Metastatic Prostate CancerTerminatedPhase 2Mayo ClinicNCT00814892Written as allogeneic tumor cell vaccine
- Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid LeukemiaWithdrawnPhase 1/2Hadassah Medical OrganizationNCT00162513Written as Allogeneic tumor cell vaccine